FDA.reportPublic FDA data

HYPROMELLOSE 2208 (100000 MPA.S)

Substance profile for UNII VM7F0B23ZI, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
VM7F0B23ZI
Preferred term
HYPROMELLOSE 2208 (100000 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300448
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300448mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300448
FDA Substance Registration SystemVM7F0B23ZIprecision.fda.gov/uniisearch/srs/unii/VM7F0B23ZI

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use DUAVEE safely and effectively. See full prescribing information for DUAVEE. DUAVEE ® (conjugated estrogens/bazedoxifene) tablets for oral use Initial U.S. approval: 20131
Drug Facts1
Theophylline Extended-Release Tablets1
Senophylline8
THEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
JANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.]16
KHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [MALLINCKRODT, INC.]11
KHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
OXYMORPHONE HYDROCHLORIDE EXTENDED-RELEASE (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.]9
DESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]7
MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]7
MEDI-DERM RX (METHYL SALICYLATE, MENTHOL AND CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]6
DOLORACIN/L RX WITH LIDOCAINE (METHYL SALICYLATE, MENTHOL, CAPSAICIN AND LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]5
THEOPHYLLINE TABLET, EXTENDED RELEASE [PLIVA INC.]5
MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]4
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED]4
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]4
DOLORACIN RX (METHYL SALICYLATE, MENTHOL AND CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]3
MEDI-DERM / L WITH LIDOCAINE (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]3
THEOPHYLLINE TABLET, EXTENDED RELEASE [CARDINAL HEALTH]3
TOPICAL PAIN RELIEF (METHYL SALICYLATE, MENTHOL, CAPSAICIN) CREAM [UNIT DOSE SERVICES]3
DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS]2
THEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]2
TOPICAL PAIN RELIEF (METHYL SALICYLATE, MENTHOL, CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]2
TOPICAL PAIN RELIEF RX (METHYL SALICYLATE MENTHOL CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]2
MEDI-DERM TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]1
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
THEOPHYLLINE (THEOPHYLLINE) TABLET, EXTENDED RELEASE [AVKARE, INC.]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [MAJOR PHARMACEUTICALS]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.]1
THEOPHYLLINE TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
XIGDUO XR (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ASTRAZENECA PHARMACEUTICALS LP]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII VM7F0B23ZI page 1 of 1 · 6 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653CAPSULEORAL161 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653CAPSULE, EXTENDED RELEASEORAL900 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653TABLETORAL1296 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653TABLET, EXTENDED RELEASEORAL2147 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653TABLET, FILM COATED, EXTENDED RELEASEORAL1320 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653LOTIONTOPICAL7 mg